Prospective and genetic analyses implicate lower immunosurveillance in the aetiology of prostate cancer.
Research paper from Europe PMC. Evidence status: source reported.
- Published
- 2026-11-10
- Source reference
- MED:43009480
- DOI
- 10.1038/s41467-026-77378-3
- Jurisdiction
- Not assessed
- Licence
- Bibliographic metadata only; article rights retained
Parsaeian M, Chan WC, Atkins JR, Papier K, Breeur M, Desai TA, Huang Z, Ogamba CF, Conti DV, Bogumil D, Shen J, Sim MJW, Tsilidis KK, Yarmolinsky J, Rinaldi S, Kaaks R, Katzke V, Schulze MB, Schiborn C, Caini S, Milani L, Zamora-Ros R, Guevara M, Sánchez MJ, Chirlaque MD, Amiano P, PRACTICAL Consortium, Elliott T, Mills IG, Riboli E, Le Marchand L, Haiman C, Key TJ, Smith-Byrne K, Travis RC. · Nat Commun · research-article; journal article; research support, n.i.h., extramural · Found via: UK Biobank
Source: https://europepmc.org/article/MED/43009480. Captured 2026-11-14.
Limitations: Discovered through a Europe PMC keyword search for UK Biobank. A mention is not a verified link to an access authorisation, project, dataset or clinical outcome. Preprints may not be peer reviewed.